The Global Fund to Fight AIDS, tuberculosis and malaria closed its eighth replenishment round with pledges totalling just $11.34bn; much lower than its ambitious $18bn goal, reported Business Day (24 Nov 2025)
Eli Lilly has become the first pharmaceutical company to reach a $1 trillion valuation, driven by surging demand for its weight-loss and diabetes drugs Mounjaro and Zepbound, reported Reuters (22 Nov 2025)
China has announced a $3.49m (approximately R60m) donation to expand critical HIV prevention funding, reported Business Day 921 November 2025)
Life Healthcare’s share price fell up to 9% after the group announced a R2.9bn adjustment to the “Piramal liability”, tied to potential earnout payments of up to $400m from the disposal of Life Molecular Imaging.